Liver International logo Blackwell Publishing logo

Publisher: Blackwell Publishing

Volume 29, Number 9, October 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

The value of serum adipokine measurement in non-alcoholic fatty liver disease
pp. 1291-1293(3)
Authors: Arrese, Marco; Riquelme, Arnoldo

Current management of hepatitis B virus infection before and after liver transplantation
pp. 1294-1305(12)
Authors: Papatheodoridis, George V.; Cholongitas, Evangelos; Archimandritis, Athanasios J.; Burroughs, Andrew K.

The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis
pp. 1307-1315(9)
Authors: Milks, Michael W.; Cripps, James G.; Lin, Heping; Wang, Jing; Robinson, Richard T.; Sargent, Jennifer L.; Whitfield, Michael L.; Gorham, James D.

Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice
pp. 1316-1325(10)
Authors: Jahnel, Jörg; Fickert, Peter; Langner, Cord; Högenauer, Christoph; Silbert, Dagmar; Gumhold, Judith; Fuchsbichler, Andrea; Trauner, Michael

Expression of liver-specific markers in naïve adipose-derived mesenchymal stem cells
pp. 1326-1337(12)
Authors: Zemel, Romy; Bachmetov, Larisa; Ad-El, Dean; Abraham, Amir; Tur-Kaspa, Ran

Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines
pp. 1338-1347(10)
Authors: Wang, Jin; Chan, Judy Yuet-Wa; Fong, Chi-Chun; Tzang, Chi-Hung; Fung, Kwok-Pui; Yang, Mengsu

An unusual cause of liver masses
pp. 1348-1349(2)
Authors: Kantarcioglu, Murat; Turan, Ilker; Karslioglu, Yildirim; Kilciler, Guldem

Early prediction of sustained virological response at day 3 of treatment with albinterferon-α-2b in patients with genotype 2/3 chronic hepatitis C
pp. 1350-1355(6)
Authors: Neumann, Avidan U.; Bain, Vincent G.; Yoshida, Eric M.; Patel, Keyur; Pulkstenis, Erik; Subramanian, G. Mani

The stable isotope ketoisocaproic acid breath test as a measure of hepatic decarboxylation capacity: a quantitative analysis in normal subjects after oral and intravenous administration
pp. 1356-1364(9)
Authors: Berthold, Heiner K.; Giesen, Thomas A. H.; Gouni-Berthold, Ioanna

Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis
pp. 1365-1371(7)
Authors: Sharma, Praveen; Sharma, Barjesh Chander; Sarin, Shiv Kumar

Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis
pp. 1372-1382(11)
Authors: Montagnese, Sara; Middleton, Benita; Skene, Debra J.; Morgan, Marsha Y.

The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population
pp. 1383-1388(6)
Authors: Cao, Bangwei; Liu, Xing; Hou, Fang; Li, Wende; Han, Zhonggang; Zhang, Qipeng; Dai, Yue; Xu, Changqing; Qi, Huimin

Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease
pp. 1389-1395(7)
Authors: Waanders, Esmé; van Keimpema, Loes; Brouwer, Johannes T.; van Oijen, Martijn G. H.; Aerts, Raymond; Sweep, Fred C. G. J.; Nevens, Frederik; Drenth, Joost P. H.

Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension
pp. 1396-1402(7)
Authors: Sam, Justina; Nguyen, Geoffrey C.

Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C
pp. 1403-1412(10)
Authors: Younossi, Zobair M.; Afendy, Arian; Stepanova, Maria; Hossain, Noreen; Younossi, Issah; Ankrah, Kathy; Gramlich, Terry; Baranova, Ancha

Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication
pp. 1413-1421(9)
Authors: Li, Chang-Zheng; Kato, Naoya; Chang, Jin-Hai; Muroyama, Ryosuke; Shao, Run-Xuan; Dharel, Narayan; Sermsathanasawadi, Radsamee; Kawabe, Takao; Omata, Masao

Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection
pp. 1422-1430(9)
Authors: Abbas, Omaima M.; Abdel-Rahman, Mohamed H.; Omar, Nabil A.; Badran, Hanaa M.; Amir, Elamir M.

Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease
pp. 1431-1438(8)
Authors: Lemoine, Maud; Ratziu, Vlad; Kim, Minji; Maachi, Mustapha; Wendum, Dominique; Paye, François; Bastard, Jean Philippe; Poupon, Raoul; Housset, Chantal; Capeau, Jacqueline; Serfaty, Lawrence

Liver fat and lipid oxidation in humans
pp. 1439-1446(8)
Authors: Kotronen, Anna; Seppälä-Lindroos, Anneli; Vehkavaara, Satu; Bergholm, Robert; Frayn, Keith N.; Fielding, Barbara A.; Yki-Järvinen, Hannele

Pregnancy and hepatitis B in Europe
pp. 1447-1447(1)
Authors: Braillon, Alain; Nguyen-Khac, Eric

Hepatitis B in pregnancy
pp. 1447-1448(2)
Author: Jonas, Maureen M.

Treating portal hypertension in cirrhotic rats with AVE 9488
pp. 1448-1448(1)
Authors: Luna, Michelle; Karavitakis, Markos

Response
pp. 1448-1449(2)
Authors: Biecker, Erwin; Trebicka, Jonel; Hennenberg, Martin; Sauerbruch, Tilman; Heller, Jörg

CORRIGENDA
pp. 1450-1450(1)

CORRIGENDA
pp. 1450-1450(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A